USPTO trademark

Eli Lilly and Company design mark 50184328

Under examinationUSPTOFigurative markClass 5

"Design mark 50184328" is a figurative mark owned by Eli Lilly and Company, filed at the USPTO on October 27, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official USPTO record
Eli Lilly and Company design mark 50184328 trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
October 27, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50184328
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Eli Lilly and Company design mark 50184328

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

8,043 trademarks in the portfolioView company

Representative

M. Daniel Spillman

Goods and services

What the mark covers

The products and services Eli Lilly and Company design mark 50184328 is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer's disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About Eli Lilly and Company design mark 50184328

Who owns the trademark "Design mark 50184328"?

The USPTO trademark "Design mark 50184328" (application 50184328) is owned by Eli Lilly and Company.

What is the status of "Design mark 50184328"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Eli Lilly and Company design mark 50184328 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a1829f-46f0-71dd-9f21-951166d28925
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a1829f-46f0-71dd-9f21-951166d28925",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50184328",
  "filing_date": "2026-10-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}